CD8A and neoplasm: As expected, we observed that SHP099 and the combination increased the density of infiltrated CD8+ cells in tumor and peritumoral areas as compared to the control subgroup, while celastrol treatment only increased the infiltrates of CD8+ cells in peritumoral areas.